Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 71437-71439 [2014-28343]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices
IV. Paperwork Reduction Act of 1995
This guidance refers to currently
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520) (the PRA). The collections of
information in 21 CFR part 801 are
approved under OMB control number
0910–0485 and the collections of
information in 21 CFR part 610, subpart
G, are approved under OMB control
number 0910–0338.
The labeling provisions recommended
in this guidance are not subject to
review by OMB because they do not
constitute a ‘‘collection of information’’
under the PRA. Rather, the
recommended labeling is a ‘‘public
disclosure of information originally
supplied by the Federal Government to
the recipient for the purpose of
disclosure to the public’’ (5 CFR
1320.3(c)(2)).
V. Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
Dated: November 25, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–28265 Filed 12–1–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1936]
Establishment of a Public Docket;
Electronic Cigarettes and the Public
Health Workshop
rljohnson on DSK3VPTVN1PROD with NOTICES
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of docket;
request for data, information, and
comments.
ACTION:
The Food and Drug
Administration (FDA), Center for
Tobacco Products, is establishing a
SUMMARY:
VerDate Sep<11>2014
15:30 Dec 01, 2014
Jkt 235001
public docket in conjunction with the
first public workshop to gather scientific
information about electronic cigarettes
(e-cigarettes) as announced in Docket
No. FDA–2014–N–0001–0079.
Regardless of attendance at the public
workshop, interested parties are invited
to submit comments, supported by
research and data, regarding electronic
cigarettes and the public health.
DATES: Submit written or electronic
comments by April 15, 2015.
ADDRESSES: Submit electronic
comments to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Caryn Cohen, Office of Science, Center
for Tobacco Products, Food and Drug
Administration, Document Control
Center, Bldg. 71, Rm. G335, 10903 New
Hampshire Ave., Silver Spring, MD
20993–0002, 1–877–287–1373, email:
workshop.CTPOS@fda.hhs.gov.
I. Background
On September 17, 2014, FDA
announced a public workshop to gather
information about e-cigarettes and the
public health (Electronic Cigarettes and
the Public Health; Public Workshop; 79
FR 55815, September 17, 2014, Docket
No. FDA–2014–N–0001). The focus of
the workshop is product science
(specifically device designs and
characteristics, and e-liquid and aerosol
constituents), product packaging,
constituent labeling, and environmental
impact. FDA intends to follow the first
workshop with two additional ecigarette workshops; one on individual
health effects and one on population
health effects. As stated in the Federal
Register notice of the public workshop,
the workshops are not intended to
inform the Agency’s deeming
rulemaking. The workshops are
intended to better inform FDA about
these products. Should the Agency
move forward as proposed to regulate ecigarettes, additional information about
the products would assist the Agency in
carrying out its responsibilities under
the law.
II. Submission of Comments
Regardless of attendance at the public
workshop, interested parties are invited
to submit comments, supported by
research and data, regarding e-cigarettes
and the public health. Information
related to workshop presentations and
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
71437
discussion topics, including specific
questions to be addressed at the
workshop, can be found at https://
www.fda.gov/TobaccoProducts/
NewsEvents/ucm238308.htm.
Interested persons may submit either
electronic comments to this docket at
https://www.regulations.gov or written
comments to the Division of Dockets
Management (see ADDRESSES). It is only
necessary to send one set of comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
Dated: November 25, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–28261 Filed 12–1–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than January 2, 2015.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUMMARY:
E:\FR\FM\02DEN1.SGM
02DEN1
71438
Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Data System for Organ Procurement and
Transplantation Network OMB No.
0915–0157—Revision.
Abstract: Section 372 of the Public
Health Service (PHS) Act requires that
the Secretary, by contract, provide for
the establishment and operation of an
Organ Procurement and Transplantation
Network (OPTN). This is a request for
revisions to current OPTN data
collection forms associated with donor
organ procurement and an individual’s
clinical characteristics at the time of
registration, transplant, and follow-up
after the transplant.
Need and Proposed Use of the
Information: Data for the OPTN data
system are collected from transplant
hospitals, organ procurement
organizations, and tissue-typing
laboratories. The information is used to
indicate the disease severity of
transplant candidates, to monitor
compliance of member organizations
with OPTN rules and requirements, and
to report periodically on the clinical and
scientific status of organ donation and
transplantation in this country. Data are
used to develop transplant, donation
and allocation policies, to determine
whether institutional members are
complying with policy, to determine
member-specific performance, to ensure
patient safety, and to fulfill the
requirements of the OPTN Final Rule.
The practical utility of the data
collection is further enhanced by
requirements that the OPTN data must
be made available, consistent with
applicable laws, for use by OPTN
members, the Scientific Registry of
Transplant Recipients, the Department
of Health and Human Services, and
members of the public for evaluation,
research, patient information, and other
important purposes.
Likely Respondents: Transplant
programs, organ procurement
organizations, histocompatibility
laboratories, medical and scientific
organizations, and public organizations.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
rljohnson on DSK3VPTVN1PROD with NOTICES
Form name
Deceased Donor Registration ..............................................
Living Donor Registration ....................................................
Living Donor Follow-up ........................................................
Donor Histocompatibility ......................................................
Recipient Histocompatibility .................................................
Heart Candidate Registration ..............................................
Heart Recipient Registration ................................................
Heart Follow Up (6 Month) ..................................................
Heart Follow Up (1–5 Year) .................................................
Heart Follow Up (Post 5 Year) ............................................
Heart Post-Transplant Malignancy Form .............................
Lung Candidate Registration ...............................................
Lung Recipient Registration .................................................
Lung Follow Up (6 Month) ...................................................
Lung Follow Up (1–5 Year) .................................................
Lung Follow Up (Post 5 Year) .............................................
Lung Post-Transplant Malignancy Form ..............................
Heart/Lung Candidate Registration .....................................
Heart/Lung Recipient Registration .......................................
Heart/Lung Follow Up (6 Month) .........................................
Heart/Lung Follow Up (1–5 Year) ........................................
Heart/Lung Follow Up (Post 5 Year) ...................................
Heart/Lung Post-Transplant Malignancy Form ....................
Liver Candidate Registration ...............................................
Liver Recipient Registration .................................................
Liver Follow-up (6 Month–5 Year) .......................................
Liver Follow-up (Post 5 Year) ..............................................
Liver Recipient Explant Pathology Form .............................
Liver Post-Transplant Malignancy .......................................
Intestine Candidate Registration ..........................................
Intestine Recipient Registration ...........................................
Intestine Follow Up (6 Month–5 Year) .................................
Intestine Follow Up (Post 5 Year) .......................................
Intestine Post-Transplant Malignancy Form ........................
Kidney Candidate Registration ............................................
Kidney Recipient Registration ..............................................
Kidney Follow-Up (6 Month–5 Year) ...................................
Kidney Follow-up (Post 5 Year) ...........................................
Kidney Post-Transplant Malignancy Form ...........................
Pancreas Candidate Registration ........................................
Pancreas Recipient Registration .........................................
VerDate Sep<11>2014
15:30 Dec 01, 2014
Jkt 235001
PO 00000
Frm 00063
Number of
responses per
respondent
58
296
296
154
154
131
131
131
131
131
131
65
65
65
65
65
65
63
63
63
63
63
63
136
136
136
136
136
136
41
41
41
41
41
235
235
235
235
235
135
135
Fmt 4703
Sfmt 4703
Total
responses
158.2
20.2
59.5
94.8
170.1
30.5
19.3
17.0
73.9
115.2
11.0
39.0
29.6
25.8
97.9
64.6
1.5
0.7
0.3
0.3
1.5
3.1
0.2
88.6
47.5
229.4
254.6
12.2
13.1
4.4
2.7
13.3
13.5
0.6
161.2
71.9
376.3
343.7
17.9
3.5
1.9
E:\FR\FM\02DEN1.SGM
9174
5984
17610
14598
26199
3991
2525
2229
9683
15091
1447
2534
1923
1677
6364
4201
99
46
21
20
97
194
12
12048
6457
31194
34622
1665
1786
182
109
547
553
25
37880
16904
88422
80770
4213
479
259
02DEN1
Average
burden per
response
(in hours)
1.1
1.8
1.3
0.2
0.4
0.9
1.4
0.4
0.9
0.5
0.9
0.9
1.4
0.5
1.1
0.6
0.4
1.1
1.4
0.8
1.1
0.6
0.4
0.8
1.3
1.0
0.5
0.6
0.8
1.3
1.8
1.5
0.4
1.0
0.8
1.3
0.9
0.5
0.8
0.9
1.1
Total burden
hours
10091.4
10771.2
22893.0
2919.6
10479.6
3591.9
3535.0
891.6
8714.7
7545.5
1302.3
2280.6
2692.2
838.5
7000.4
2520.6
39.6
50.6
29.4
16.0
106.7
116.4
4.8
9638.4
8394.1
31194.0
17311.0
999.0
1428.8
236.6
196.2
820.5
221.2
25.0
30304.0
21975.2
79579.8
40385.0
3370.4
431.1
284.9
71439
Federal Register / Vol. 79, No. 231 / Tuesday, December 2, 2014 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Pancreas Follow-up (6 Month–5 Year) ................................
Pancreas Follow-up (Post 5 Year) ......................................
Pancreas Post-Transplant Malignancy Form ......................
Kidney/Pancreas Candidate Registration ............................
Kidney/Pancreas Recipient Registration .............................
Kidney/Pancreas Follow-up (6 Month–5 Year) ....................
Kidney/Pancreas Follow-up (Post 5 Year) ..........................
Kidney/Pancreas Post-Transplant Malignancy Form ..........
Vascular Composite Allograft Candidate Registration ........
Vascular Composite Allograft Recipient Registration ..........
Vascular Composite Allograft Recipient Follow Up .............
135
135
135
13
135
135
135
135
16
16
16
10.4
13.4
0.8
98.5
5.6
33.4
47.9
1.6
0.9
0.9
0.9
1398
1804
108
1280
760
4509
6465
211
15
15
15
1.0
0.5
0.6
0.9
1.1
1.0
0.6
0.4
0.4
1.3
1.0
1398.0
902.0
64.8
1152
836.0
4509.0
3879.0
84.4
6.0
19.5
15.0
Total ..............................................................................
* 456
........................
460414
........................
358092.5
* Total number of OPTN member institutions as of 09/9/2014. Number of respondents for transplant candidate or recipient forms based on
number of organ specific programs associated with each form.
Jackie Painter,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2014–28343 Filed 12–1–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than January 2, 2015.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
rljohnson on DSK3VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:30 Dec 01, 2014
Jkt 235001
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
The Health Professions Student Loan
(HPSL) and Nursing Student Loan (NSL)
Programs: Deferment-HRSA Form 519
and AOR–HRSA Form 501, OMB No.
0915–0044-Extension
Abstract: The HPSL Program, as
authorized by Public Health Service
(PHS) Act sections 721–722, and 725–
735, provides long-term, low-interest
loans to students attending schools of
medicine, osteopathic medicine,
dentistry, veterinary medicine,
optometry, podiatric medicine, and
pharmacy. The NSL program as
authorized by PHS Act sections 835–
842, provides long-term, low-interest
loans to students who attend eligible
schools of nursing in programs leading
to a diploma in nursing, including an
associate degree, a baccalaureate degree,
or graduate degree in nursing.
Need and Proposed Use of the
Information: Participating HPSL and
NSL schools are responsible for
determining eligibility of applicants,
making loans, and collecting monies
owed by borrowers on their outstanding
loans. The Deferment Form (DefermentHRSA Form 519) provides the schools
with documentation of a borrower’s
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
deferment status, as detailed for the
HPSL program under 42 CFR 57.210 and
for NSL under 42 CFR 57.310. The
Annual Operating Report (AOR–HRSA
Form 501) provides the U.S. Department
of Health and Human Services with
information from participating schools
(including schools that are no longer
disbursing loans but are required to
report and maintain program records,
student records, and repayment records
until all student loans are repaid in full
and all monies due to the federal
government are returned) relating to
HPSL and NSL program operations and
financial activities.
Likely Respondents: Financial Aid
Directors working at institutions
participating in the HPSL and NSL
Programs.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
E:\FR\FM\02DEN1.SGM
02DEN1
]]>Agencies
[Federal Register Volume 79, Number 231 (Tuesday, December 2, 2014)]
[Notices]
[Pages 71437-71439]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28343]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health Resources and Services Administration
(HRSA) has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received no later than January 2,
2015.
ADDRESSES: Submit your comments, including the Information Collection
Request Title, to the desk officer for HRSA, either by email to
OIRA_submission@omb.eop.gov or by fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
[[Page 71438]]
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Data System for Organ
Procurement and Transplantation Network OMB No. 0915-0157--Revision.
Abstract: Section 372 of the Public Health Service (PHS) Act
requires that the Secretary, by contract, provide for the establishment
and operation of an Organ Procurement and Transplantation Network
(OPTN). This is a request for revisions to current OPTN data collection
forms associated with donor organ procurement and an individual's
clinical characteristics at the time of registration, transplant, and
follow-up after the transplant.
Need and Proposed Use of the Information: Data for the OPTN data
system are collected from transplant hospitals, organ procurement
organizations, and tissue-typing laboratories. The information is used
to indicate the disease severity of transplant candidates, to monitor
compliance of member organizations with OPTN rules and requirements,
and to report periodically on the clinical and scientific status of
organ donation and transplantation in this country. Data are used to
develop transplant, donation and allocation policies, to determine
whether institutional members are complying with policy, to determine
member-specific performance, to ensure patient safety, and to fulfill
the requirements of the OPTN Final Rule. The practical utility of the
data collection is further enhanced by requirements that the OPTN data
must be made available, consistent with applicable laws, for use by
OPTN members, the Scientific Registry of Transplant Recipients, the
Department of Health and Human Services, and members of the public for
evaluation, research, patient information, and other important
purposes.
Likely Respondents: Transplant programs, organ procurement
organizations, histocompatibility laboratories, medical and scientific
organizations, and public organizations.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Deceased Donor Registration..... 58 158.2 9174 1.1 10091.4
Living Donor Registration....... 296 20.2 5984 1.8 10771.2
Living Donor Follow-up.......... 296 59.5 17610 1.3 22893.0
Donor Histocompatibility........ 154 94.8 14598 0.2 2919.6
Recipient Histocompatibility.... 154 170.1 26199 0.4 10479.6
Heart Candidate Registration.... 131 30.5 3991 0.9 3591.9
Heart Recipient Registration.... 131 19.3 2525 1.4 3535.0
Heart Follow Up (6 Month)....... 131 17.0 2229 0.4 891.6
Heart Follow Up (1-5 Year)...... 131 73.9 9683 0.9 8714.7
Heart Follow Up (Post 5 Year)... 131 115.2 15091 0.5 7545.5
Heart Post-Transplant Malignancy 131 11.0 1447 0.9 1302.3
Form...........................
Lung Candidate Registration..... 65 39.0 2534 0.9 2280.6
Lung Recipient Registration..... 65 29.6 1923 1.4 2692.2
Lung Follow Up (6 Month)........ 65 25.8 1677 0.5 838.5
Lung Follow Up (1-5 Year)....... 65 97.9 6364 1.1 7000.4
Lung Follow Up (Post 5 Year).... 65 64.6 4201 0.6 2520.6
Lung Post-Transplant Malignancy 65 1.5 99 0.4 39.6
Form...........................
Heart/Lung Candidate 63 0.7 46 1.1 50.6
Registration...................
Heart/Lung Recipient 63 0.3 21 1.4 29.4
Registration...................
Heart/Lung Follow Up (6 Month).. 63 0.3 20 0.8 16.0
Heart/Lung Follow Up (1-5 Year). 63 1.5 97 1.1 106.7
Heart/Lung Follow Up (Post 5 63 3.1 194 0.6 116.4
Year)..........................
Heart/Lung Post-Transplant 63 0.2 12 0.4 4.8
Malignancy Form................
Liver Candidate Registration.... 136 88.6 12048 0.8 9638.4
Liver Recipient Registration.... 136 47.5 6457 1.3 8394.1
Liver Follow-up (6 Month-5 Year) 136 229.4 31194 1.0 31194.0
Liver Follow-up (Post 5 Year)... 136 254.6 34622 0.5 17311.0
Liver Recipient Explant 136 12.2 1665 0.6 999.0
Pathology Form.................
Liver Post-Transplant Malignancy 136 13.1 1786 0.8 1428.8
Intestine Candidate Registration 41 4.4 182 1.3 236.6
Intestine Recipient Registration 41 2.7 109 1.8 196.2
Intestine Follow Up (6 Month-5 41 13.3 547 1.5 820.5
Year)..........................
Intestine Follow Up (Post 5 41 13.5 553 0.4 221.2
Year)..........................
Intestine Post-Transplant 41 0.6 25 1.0 25.0
Malignancy Form................
Kidney Candidate Registration... 235 161.2 37880 0.8 30304.0
Kidney Recipient Registration... 235 71.9 16904 1.3 21975.2
Kidney Follow-Up (6 Month-5 235 376.3 88422 0.9 79579.8
Year)..........................
Kidney Follow-up (Post 5 Year).. 235 343.7 80770 0.5 40385.0
Kidney Post-Transplant 235 17.9 4213 0.8 3370.4
Malignancy Form................
Pancreas Candidate Registration. 135 3.5 479 0.9 431.1
Pancreas Recipient Registration. 135 1.9 259 1.1 284.9
[[Page 71439]]
Pancreas Follow-up (6 Month-5 135 10.4 1398 1.0 1398.0
Year)..........................
Pancreas Follow-up (Post 5 Year) 135 13.4 1804 0.5 902.0
Pancreas Post-Transplant 135 0.8 108 0.6 64.8
Malignancy Form................
Kidney/Pancreas Candidate 13 98.5 1280 0.9 1152
Registration...................
Kidney/Pancreas Recipient 135 5.6 760 1.1 836.0
Registration...................
Kidney/Pancreas Follow-up (6 135 33.4 4509 1.0 4509.0
Month-5 Year)..................
Kidney/Pancreas Follow-up (Post 135 47.9 6465 0.6 3879.0
5 Year)........................
Kidney/Pancreas Post-Transplant 135 1.6 211 0.4 84.4
Malignancy Form................
Vascular Composite Allograft 16 0.9 15 0.4 6.0
Candidate Registration.........
Vascular Composite Allograft 16 0.9 15 1.3 19.5
Recipient Registration.........
Vascular Composite Allograft 16 0.9 15 1.0 15.0
Recipient Follow Up............
-------------------------------------------------------------------------------
Total....................... * 456 .............. 460414 .............. 358092.5
----------------------------------------------------------------------------------------------------------------
* Total number of OPTN member institutions as of 09/9/2014. Number of respondents for transplant candidate or
recipient forms based on number of organ specific programs associated with each form.
Jackie Painter,
Acting Director, Division of Policy and Information Coordination.
[FR Doc. 2014-28343 Filed 12-1-14; 8:45 am]
BILLING CODE 4165-15-P
